EcoDrugPlus

Ensembl ID : ENSOMYG00000027002
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOMYG00000012918
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOMYG00000007869
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000005532
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSOMYG00000039386
Gene Symbol: -
1 Cross references
492 Possible Orthologues:

Ensembl ID : ENSOMYG00000070738
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSOMYG00000039436
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Ensembl ID : ENSOMYG00000070547
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSOMYG00000070089
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSOMYG00000069983
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSOMYG00000039970
Gene Symbol: -
Cross references: -
409 Possible Orthologues:

Ensembl ID : ENSOMYG00000040007
Gene Symbol: -
Cross references: -
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).